Ever since he sold his startup Broadcast.com to Yahoo for $5.7 billion in 1999 to become an instant billionaire, Mark Cuban has followed his curiosity into a wild array of fields, from health care to fintech to media, consumer products, and, of course, sports. Where others might have settled into a comfy life as an NBA owner/playboy, he became a kind of super-entrepreneur, not only investing in a diversified portfolio of startups, but getting deeply involved in some as well, even co-founding a few.
Perhaps the biggest entrepreneurial swing he has taken since Broadcast.com is his new healthcare initiative. Some three years ago, Cuban got an email from a 33-year-old radiologist named Alex Oshmyansky, with the subject line "Cold pitch." Oshmyansky wanted Cuban to invest in a pharmacy he was starting to custom-make generic drugs and skip the layer of middleman wholesalers and so-called pharmacy benefit managers, which are typically responsible for heavy markups.
This all happened back in early 2019--and by the following year Cuban had not only invested in Oshmyansky's idea but also signed on as a co-founder of a now much more ambitious company. Read on for our latest cover story on Mark Cuban and his ambitions to take on a new giant: big pharma.
Post a Comment
Note: Only a member of this blog may post a comment.